Tag Archives: Says

Vaping illness outbreak could lead to marijuana legalization, Tilray CEO says

The deadly lung illness linked to vaping could prompt the United States and others to legalize marijuana, Tilray CEO Brendan Kennedy told CNBC on Tuesday. “All the products that we produce in Canada and produce around the world are well tested by not only Health Canada, but regulators in other countries,” Kennedy told “Closing Bell.”… Read More »

CDC says it’s made a breakthrough in finding possible cause of deadly vaping illness

U.S. health officials finally have a potential breakthrough in the vaping illness outbreak that’s killed at least 39 people, narrowing in on vitamin E acetate as a “potential toxin of concern,” Centers for Disease Control and Prevention officials said Friday. The compound used in supplements, cosmetics and some vaping products was detected in all 29… Read More »

Practices need to vastly improve data accuracy in records, attorney says

The processes of medical recordkeeping continue to change, as regulators more frequently set new requirements, and many healthcare organizations struggle to keep up with the changes. But the big problem is that too many hospitals and practices still haven’t managed the basics of collecting and reporting data for regulators and attorneys, Isabelle Bebit-Kilinyak, a corporate… Read More »

Vaping Illnesses Increase to 530 Probable Cases, C.D.C. Says

The number of vaping-related lung illnesses has risen to 530 probable cases, according to an update on Thursday by the Centers for Disease Control and Prevention, and a Missouri man became the eighth to die from the mysterious ailments. During a news briefing, Dr. Anne Schuchat, principal deputy director of the C.D.C., said officials expect… Read More »

FDA says some data testing Novartis’ $2 million gene therapy was manipulated

NEW YORK (Reuters) – The U.S. Food and Drug Administration said on Tuesday that some data from early testing of Novartis’ more than $ 2 million gene therapy Zolgensma was manipulated, but the agency believes the treatment should remain on the market. FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is… Read More »